{"title":"CD4<sup>+</sup> tissue-resident memory T cells and their role in immunity.","authors":"Margarida Kirkby, Marc Veldhoen","doi":"10.1111/imcb.70052","DOIUrl":null,"url":null,"abstract":"<p><p>CD4<sup>+</sup> tissue-resident memory T (T<sub>RM</sub>) cells are essential for immune protection in the lungs, providing rapid responses against respiratory pathogens. Unlike circulating memory T cells, CD4<sup>+</sup> T<sub>RM</sub> cells persist in the tissue parenchyma and possibly inducible lymphoid tissues, where they facilitate pathogen clearance through cytokine production and interactions with local immune cells. While CD8<sup>+</sup> T<sub>RM</sub> cells are well studied, the role of CD4<sup>+</sup> T<sub>RM</sub> cells in immunity remains less defined and is the focus of this review. Distinct subsets, based on the effector T<sub>H</sub>1, T<sub>H</sub>2, T<sub>H</sub>17 and T follicular helper (T<sub>FH</sub>)-like tissue-resident helper (T<sub>RH</sub>) cells, contribute to antiviral, antibacterial, antifungal and vaccine-induced immunity. CD4<sup>+</sup> T<sub>RM</sub> cells play a key role in infections, enhancing immune responses and supporting antibody production. However, they are also implicated in chronic inflammation, allergies and fibrosis. Given their importance, vaccines aiming to elicit lung-resident CD4<sup>+</sup> T<sub>RM</sub> cells, particularly via mucosal delivery, have shown promise in inducing long-term protective immunity. Intranasal vaccination strategies, such as live-attenuated influenza virus and tuberculosis vaccines, have successfully generated CD4<sup>+</sup> T<sub>RM</sub> cells, highlighting their potential for respiratory pathogen control. In this review, we focus on CD4<sup>+</sup> T<sub>RM</sub> cells, their differentiation, maintenance and role, especially in the lungs.</p>","PeriodicalId":179,"journal":{"name":"Immunology & Cell Biology","volume":" ","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2025-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immunology & Cell Biology","FirstCategoryId":"2","ListUrlMain":"https://doi.org/10.1111/imcb.70052","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
CD4+ tissue-resident memory T (TRM) cells are essential for immune protection in the lungs, providing rapid responses against respiratory pathogens. Unlike circulating memory T cells, CD4+ TRM cells persist in the tissue parenchyma and possibly inducible lymphoid tissues, where they facilitate pathogen clearance through cytokine production and interactions with local immune cells. While CD8+ TRM cells are well studied, the role of CD4+ TRM cells in immunity remains less defined and is the focus of this review. Distinct subsets, based on the effector TH1, TH2, TH17 and T follicular helper (TFH)-like tissue-resident helper (TRH) cells, contribute to antiviral, antibacterial, antifungal and vaccine-induced immunity. CD4+ TRM cells play a key role in infections, enhancing immune responses and supporting antibody production. However, they are also implicated in chronic inflammation, allergies and fibrosis. Given their importance, vaccines aiming to elicit lung-resident CD4+ TRM cells, particularly via mucosal delivery, have shown promise in inducing long-term protective immunity. Intranasal vaccination strategies, such as live-attenuated influenza virus and tuberculosis vaccines, have successfully generated CD4+ TRM cells, highlighting their potential for respiratory pathogen control. In this review, we focus on CD4+ TRM cells, their differentiation, maintenance and role, especially in the lungs.
期刊介绍:
The Australasian Society for Immunology Incorporated (ASI) was created by the amalgamation in 1991 of the Australian Society for Immunology, formed in 1970, and the New Zealand Society for Immunology, formed in 1975. The aim of the Society is to encourage and support the discipline of immunology in the Australasian region. It is a broadly based Society, embracing clinical and experimental, cellular and molecular immunology in humans and animals. The Society provides a network for the exchange of information and for collaboration within Australia, New Zealand and overseas. ASI members have been prominent in advancing biological and medical research worldwide. We seek to encourage the study of immunology in Australia and New Zealand and are active in introducing young scientists to the discipline.